Mayo Clinic and Vocalis Health announced a collaboration to research and develop new voice-based tools for screening, detecting, and…
Articles by Marisa Wexler, MS
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
Treatment with Tyvaso (inhaled treprostinil) can improve lung function in people with pulmonary hypertension associated with…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
The combination of pulmonary endarterectomy (PEA), a surgery to remove blood clots in the lungs, and balloon pulmonary…
The U.S. Food and Drug Administration (FDA) has granted SoniVie permission to begin a pivotal clinical trial of…
The combination of Opsumit (macitentan) and Adcirca (tadalafil) is a safe and effective initial treatment for pulmonary…
The U.S. Food and Drug Administration (FDA) has accepted for review the  application for Tyvaso (inhaled treprostinil) as a…
High pulmonary vascular resistance (PVR) is associated with worse mortality rates among people with pulmonary hypertension (PH), and the bottom…
People with pulmonary arterial hypertension (PAH) who are treated at specialty care centers have better survival chances and a…
U.S. veterans with pulmonary hypertension (PH) due to left heart disease and chronic lung disease are more likely to…
At-home treatment with inhaled nitric oxide through Genosyl, a tankless delivery system, was used successfully to manage pulmonary…